BLGOBiolargo Inc

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

N/A

Location

California, USA

Exchange

OTC

Website

https://biolargo.com

Summary

BioLargo, Inc.

Company Info

CEO

N/A

Location

California, USA

Exchange

OTC

Website

https://biolargo.com

Summary

BioLargo, Inc.

AI Insights for BLGO
5 min read

Quick Summary

BioLargo, Inc. is a small U.S.-based environmental technology and engineering company focused on inventing, developing, and commercializing platform technologies. The company operates in the chemicals and manufacturing sector, but its business is centered on water treatment, wastewater treatment, air quality, odor control, volatile organic compound mitigation, infection control, and related environmental engineering services. Its technology portfolio includes systems designed to address difficult contaminants such as PFAS, as well as oxidation-based treatment methods for water and industrial applications. BioLargo sells or seeks to monetize its products through equipment sales, service contracts, licensing, joint ventures, engineering projects, and intellectual property transactions. Its main customers are likely industrial operators, municipal water and wastewater entities, environmental remediation firms, consumer-product partners, and companies needing specialized engineering solutions for contamination, odor, or air-quality problems.

Strengths

•

BioLargo’s main strength is its portfolio of patented or proprietary environmental technologies targeting large and urgent markets.

•

PFAS remediation, water treatment, wastewater treatment, air quality, odor control, and VOC mitigation are all areas with long-term regulatory and commercial demand.

•

The company’s engineering division gives it internal technical capabilities to develop, test, and scale its own systems rather than relying entirely on outside contractors.

•

The company also appears to have made progress historically in reducing convertible debt, which can reduce dilution pressure and balance-sheet complexity.

•

Its small size may allow it to be flexible in structuring partnerships, licensing agreements, joint ventures, and niche customer solutions.

Key Risks

•

BioLargo faces significant execution risk because its valuation depends heavily on future commercialization rather than current profitability.

•

The company may need additional financing if losses continue, and any equity financing could dilute existing shareholders.

•

Technology adoption risk is also high because customers in water treatment and PFAS remediation often require extensive validation, regulatory confidence, and long sales cycles before making purchases.

•

Legal, reputational, or financial fallout from the POOPH and ONM dispute could harm relationships and distract management.

What to Watch

The most recent reported fundamental period is listed as Q3 2026, and the data show BioLargo remained a small revenue company with continuing losses.
Revenue was approximately $1.248 million, gross profit was approximately $675,000, and net income was approximately negative $4.0 million.
Operating income was also negative at approximately $3.728 million, indicating that the company’s operating expense base remains high relative to its current revenue.
No specific new product launch, partnership, or earnings date was provided in the supplied quarter data, so the quarter appears more defined by financial performance and ongoing commercialization efforts than by a clearly identified milestone.
The recent news set also includes a negative supply-chain and quality-control development involving POOPH and ONM, as well as an older positive balance-sheet development involving the reduction of convertible debt.

Price Drivers

•

BioLargo’s stock price is likely driven by commercialization progress, revenue growth, financing needs, and investor appetite for speculative environmental technology companies.

•

The company reported operating revenue of about $1.248 million, gross profit of about $675,000, operating income of about negative $3.728 million, and net income of about negative $4.0 million, which indicates that losses remain a major valuation factor.

•

The market capitalization of about $30.2 million and EV-to-revenue ratio of about 8.09 suggest investors may be valuing the company based on future technology potential rather than current profitability.

•

News involving PFAS regulation, water treatment demand, pilot projects, commercial contracts, debt reduction, litigation, or partner disputes can materially affect sentiment because the company is small and trades on the OTC market.

•

The recent POOPH supplier termination and complaint could pressure confidence, while evidence of successful AOS or AEC commercialization could support the share price.

Recent News

•

Recent news includes POOPH, Inc. terminating supplier ONM, a subsidiary of BioLargo, under a contract provision citing failure to deliver required products.

•

POOPH also filed a verified complaint in Orange County Superior Court alleging quality-control problems such as incorrect bottles, leaking packaging, poor labeling, faulty sprayers, and substandard products.

•

This news is negative because it raises concerns about BioLargo-related supply-chain execution, customer satisfaction, and potential legal exposure.

•

Another supplied news item states that BioLargo eliminated nearly all of its convertible debt by paying off $406,000 due in August 2021 using cash and equity.

•

That older debt-reduction news was positive because it suggested management had reduced balance-sheet pressure while continuing to pursue commercialization of AOS, AEC, and environmental engineering services.

Market Trends

•

BioLargo operates in markets supported by strong long-term trends in environmental regulation, water scarcity, contamination remediation, and public-health awareness.

•

PFAS regulation is becoming more important in the United States and other markets, which may increase demand for technologies that can remove or concentrate persistent chemicals from water.

•

Municipalities, industrial operators, and regulators are increasingly focused on cost-effective treatment systems that reduce energy use, waste generation, and lifecycle costs.

•

At the same time, customers tend to favor proven vendors with strong balance sheets, which can make adoption difficult for small emerging technology companies.

•

Higher interest rates, tighter capital markets, and risk-off investor sentiment can also pressure speculative OTC stocks even when the long-term environmental market opportunity remains attractive.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on BLGO

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show